Business Context and Reporting Period
This Form 6-K filing by VCI Global Limited covers the month of January 2026. The report details a Registered Direct Offering entered into on January 20, 2026, with a single institutional investor. The offering is structured in three tranches of $5 million each, with the initial closing occurring on January 21, 2026.
Key Financial Metrics
- Gross Proceeds (Initial Closing): Approximately $5 million.
- Securities Issued (Initial Closing): 3,179,716 ordinary shares, Pre-Funded Warrants for up to 5,393,672 shares, Common A Warrants for up to 8,573,388 shares, and Common B Warrants for up to 8,573,388 shares.
- Placement Fee: 7.0% of gross proceeds paid to E.F. Hutton & Co.
- Warrant Exercise Prices: $0.8020 per share for both Common A and Common B Warrants.
- Warrant Terms: Common A Warrants have a 5-year term; Common B Warrants have an 180-day term.
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the execution of the securities purchase agreement and the completion of the Initial Closing, resulting in the issuance of new equity and warrant instruments. The filing does not provide comparative financial data against prior periods to quantify changes in operational metrics.
Outlook, Risks, and Contingencies
- Future Closings: The First and Second Tranche Closings (totaling an additional $10 million potential) are contingent upon the satisfaction of specific conditions, including trading price and trading volume requirements immediately prior to the closing dates.
- Warrant Provisions: Common A Warrants include cashless exercise and forced exercise provisions.
- Legal Opinions: Validity opinions regarding the securities were provided by Carey Olsen (BVI) L.P. and Sichenzia Ross Ference Carmel LLP.
Investor Verification Checklist
- Verify the current trading price and volume of VCI Global Limited ordinary shares to assess the likelihood of the First and Second Tranche Closings occurring.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific details on the forced exercise and cashless exercise provisions of the Common A Warrants.
- Confirm the dilution impact of the Pre-Funded Warrants and Common Warrants on existing shareholders.
- Check the Prospectus Supplement filed on January 21, 2026, for a complete description of the offering terms and risk factors.